# Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device

> **NCT02255890** · — · UNKNOWN · sponsor: **Clinical Research Office of the Endourological Society** · enrollment: 361 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02255890
- **Lead sponsor:** Clinical Research Office of the Endourological Society
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2020-06
- **Final completion:** 2025-04
- **Target enrollment:** 361 (ESTIMATED)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255890, "Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02255890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*